Stuart Stoller
Family Medicine · Sterling Heights, MINPI 1184665713
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,001 of the $4,501 with a category attached, or 66.7%. 20 manufacturers reported payments, led by Novo Nordisk AS at 41.0% of the total. Among family medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 268 payments — averaging $16.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$2K
- Boehringer Ingelheim$492
- Novo Nordisk$422
- Amgen$279
- Sunovion Pharmaceuticals Inc.$202
- Lilly USA, LLC$199
- plus $1K from 14 others
Across 98 payments — averaging $1390.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$75K
- Novartis$48K
- Boehringer Ingelheim$12K
- Boehringer Ingelheim B.v.$1K
What the payments were for
- Travel & lodging$1,48233%
- Food & beverage$3,00167%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 6 | $1,844 |
| Boehringer Ingelheim | 19 | $492 |
| Novo Nordisk | 84 | $422 |
| Amgen | 18 | $279 |
| Sunovion Pharmaceuticals Inc. | 26 | $202 |
| Lilly USA, LLC | 32 | $199 |
| Johnson & Johnson | 17 | $196 |
| Merck | 18 | $192 |
| Pfizer | 17 | $180 |
| Amarin Pharma, Inc. | 9 | $138 |
| AstraZeneca | 5 | $71 |
| Mylan Specialty L.p. | 3 | $49 |
| GSK | 3 | $47 |
| Sanofi-aventis U.S. LLC | 3 | $47 |
| Melinta Therapeutics, LLC | 2 | $46 |
| Novartis | 2 | $25 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| AbbVie | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Medicure Pharma Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$1,844
How this compares
$4,501 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Sterling Heights
- Jeffrey DeitchSterling Heights$197K
- Steven MargolisSterling Heights$90K
- Mark RosenbergSterling Heights$17K
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
- Farhan BhattiLansing$230K
- Sukhpreet SinghPlymouth$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.